- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01323725
Team-based Financial Incentives for Smoking Cessation (StPaulKorea)
The Effectiveness of Team-based Financial Incentives for Increasing Long-term Smoking Cessation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
About 70% of smokers report that they want to quit, but annually 2 to 3% of smokers succeed. Smoking-cessation programs and pharmacologic therapies have been proven effective in helping smokers quit, but only a few smokers are enrolled in those programs.
Financial incentives may contribute to reinforce smoking cessation among workers through the following pathways: (1) increasing the number of tobacco users who participate in cessation effort; (2) increasing the number of tobacco user who initiate an attempt to quit; and (3) increasing the number of tobacco users who sustain a successful quit effort. Moreover, there is a number of advantages to offering smoking cessation support in the workplace, including the accessibility of the target population, the availability of occupational health support and the potential for peer pressure and peer support. In addition, team-based approach for smoking cessation could likely make use of new or existing cessation support resources offered within the workplace.
This study is a clinical trial of team-based financial incentives for smoking cessation among a sample of 60 smokers, who are health care workers from St. Paul's Hospital in Korea. Smokers will be given a usual care (counseling, education and coverage of prescription drugs) plus a package of financial incentives for self-reported and biochemically validated smoking cessation (urine or saliva cotinine). All incentives will be provided to each team at 6 months post-quit date.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- St.Paul's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Employees of St. Paul's Hospital at work sites in Korea
- Current smoker who report having smoked at least 5 cigarettes per day for the prior 12 months
- Age 18 or older
Exclusion Criteria:
- Age 17 or younger
- Unwilling to quit smoking
- Smoker who does not want to be enrolled in this trial
- Planning to leave St. Paul's hospital within the next 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Team-based financial incentives
|
Team-based financial incentives for smoking cessation at 6 month post-quit date.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking Cessation Rate
Time Frame: 6 months
|
Self-reported and biochemically validated smoking cessation rate at 6 months post-quit date
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking Cessation Rate
Time Frame: 3, 9, 12 months
|
Self-reported and biochemically validated smoking cessation rate at 3, 9, 12 months post-quit date
|
3, 9, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sang Haak Lee, MD, St. Paul's Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- StPaulKorea
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.